Fineotex Chemical Limited
Financial trend (100/100) does the heavy lifting; valuation (1/100) is the drag.
ExpensiveOvervaluedOur blended model reads Fineotex Chemical Limited as a Hold at 45/100. At ₹39.32 it trades above our blended DCF and relative-multiples fair value of ₹19.66, about 50% downside to that estimate — we read it as overvalued by 50%. On 96.6x trailing earnings it sits pricier than the Basic Materials median of about 22.2x. The price is about 13% below its 52-week high of ₹45.41 and 104% above the low of ₹19.24. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 3/9. The average analyst target of ₹39.5 is roughly in line with the current price across 2 analysts. It clears 6 of 11 investability checks, with durability 74, valuation 1 and momentum 74 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹15.73.
Analyst views
1-year price
EOD · 2026-07-3152-week range
-13.41% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Hold45Piotroski F-score 3/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- No data: ROE above 15%
- Pass: Low debt (D/E < 0.5): 0.01x
- Fail: Positive free cash flow
- Pass: Revenue growth > 10%: 182%
- Pass: Earnings growing: 88%
- Pass: Net margin ≥ 10%: 12.1%
- No data: Current ratio > 1.5
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Pass: Above 200-day average
- Fail: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 14.29
- Fail: Piotroski ≥ 7: 3/9
Quarterly results
Annual financials
Shareholding
- Promoter67.2%
- Institutions1.6%
- Public & other31.2%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Lightly leveraged balance sheet.
- Financially solid — Altman Z 14.29.
Opportunities
- Earnings growing (88% YoY).
- Revenue growing (182% YoY).
Bear case
Weaknesses
- Weak Piotroski score (3/9).
Threats
- Rich valuation versus sector peers.
- Trades ~50% above our estimated fair value.
About Fineotex Chemical Limited
Fineotex Chemical Limited manufactures and sells textile chemicals, auxiliaries, and specialty chemicals in India and United States. The company provides textile chemicals for pre-treatment, dyeing, printing, and finishing processes, as well as enzymes; water treatment chemicals; and oilfield chemicals, such as drilling fluids, cementing fluids, production chemicals, and fracturing solutions. It also offers cleaning and hygiene products, including disinfection, housekeeping,
Fineotex Chemical Limited — frequently asked questions
Is Fineotex Chemical Limited a buy, hold or sell?
StocksWizard currently rates Fineotex Chemical Limited (FCL) a Hold, based on a blended score of 45/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Fineotex Chemical Limited's fair value?
Our blended DCF and relative-valuation model estimates Fineotex Chemical Limited's fair value at about ₹19.66, versus a current price of ₹39.32 — roughly 50% downside. On that basis the stock looks overvalued by 50%.
Is Fineotex Chemical Limited financially healthy?
Fineotex Chemical Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 3/9.
How has Fineotex Chemical Limited's share price performed?
Fineotex Chemical Limited is up 69% over three months, and last traded at ₹39.32. Past performance doesn't predict future returns.
More in Basic Materials
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.